Most Popular Choices
Share on Facebook 55 Printer Friendly Page More Sharing Summarizing
General News    H3'ed 8/19/21  

Alabama Docs Call Monoclonal Antibody Treatment "The Answer" to Hospital Surge

Quicklink Submitted By   No comments

Steve Schneider

ICU beds are filling up in Alabama, and the surge in people seriously ill with Covid-19 is expected to increase in the next few weeks, according to a report at Al.com.

But doctors in Alabama feel they've got a way to help keep people from getting sick enough to require hospitalization.   “This is the golden goose, okay, this is what we need, and we’ve got a short window to get these people treated,” said Dr. David Thrasher, a pulmonologist from Montgomery. “This is the only thing in COVID that I’ve seen that is not controversial.”

He was talking about monoclonal antibody treatment.   According to Al.com, "Monoclonal antibodies are a synthetic treatment that help the body build rapid immunity to COVID-19. The treatment, which has Emergency Use Authorization from the FDA, prevents hospitalization in about 70 percent of COVID-19 patients."

Read the rest of the story HERE:

At www.al.com
Rate It | View Ratings

Steve Schneider Social Media Pages: Facebook page url on login Profile not filled in       Twitter Page       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Steve Schneider lives in South Florida. He writes articles for Op Ed News and Democracy Chronicles.

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter

Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend